Helping chronic stroke patients regain independence with biophoton therapy
Can Participants With Chronic Stroke Regain Living Independence by Daily Energizing With a Biophoton Generator
NA · First Institute of All Medicines · NCT06049849
This study is testing if daily use of a special light therapy can help people who have had a stroke regain their independence and live on their own again.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 46 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | First Institute of All Medicines (other) |
| Locations | 1 site (Butler, Pennsylvania) |
| Trial ID | NCT06049849 on ClinicalTrials.gov |
What this trial studies
This clinical research aims to determine if daily use of Testa BioHealing® Biophoton Generators can help patients with chronic stroke regain the ability to live independently. The study involves a randomized, triple-blinded, placebo-controlled design with at least 46 participants who will stay at a Tesla MedBed Center. Participants will either receive active biophoton treatment or a placebo while continuing their standard of care. Their progress will be monitored through questionnaires and assessments over a four-week period.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who have experienced a stroke at least six months prior and are unable to live independently.
Not a fit: Patients with untreated psychiatric disturbances or severe co-morbid conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly enhance the quality of life for chronic stroke patients by improving their independence.
How similar studies have performed: While this approach is novel, similar studies using energy-based therapies have shown promise in improving patient outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Must be 18-years or older and can live in a hotel * Must have a caregiver willing to support the participant's full involvement in the study and can assist to complete all study questionnaires * Can provide informed consent (maybe assisted by Caregiver) * Has evidence of a clinical diagnosis of stroke occurred at least 6 months ago. * Has a disability unable to be living independently per Caregiver * Can complete all study procedures during the study * Must be fluent in English (or the Caregiver can fully translate) Exclusion Criteria: * Untreated psychiatric disturbances that would affect trial participation as judged by the Caregiver or by the clinical study medical professional * Who relies on ventilators * Co-morbid conditions that would interfere with study activities or response to treatment, which may include severe chronic pulmonary disease, history of uncontrolled seizures, acute or chronic infectious illness, kidney failure, etc. * Is participating in another investigational drug or device trial
Where this trial is running
Butler, Pennsylvania
- Tesla MedBed Center at Butler-PA — Butler, Pennsylvania, United States (RECRUITING)
Study contacts
- Study coordinator: Jessica Jackson
- Email: jessica.jackson@firstallmed.org
- Phone: 3029222486
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Chronic Stroke, stroke, paralysis